It is no secret that the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is expected to drive care delivery and payment reform across the US health care system for the near future. It has the potential to be a complete game changer to the U.S. Health care industry. Based on the Deloitte Center for Health Solutions 2016 Survey of U.S. physicians, Fifty percent of physicians surveyed say they have never heard of the law and 32 percent recognize it by name but are not familiar with its requirements.
Deloitte Consulting LLP has successfully dealt with the proposed rule and we can share our insight in how providers and health systems can thrive in this new environment.
During this discussion, we will explore:
· The proposed rule and how the two new tracks for clinician payment will be structured and have a near-term financial impact.
· Implications for health systems and other stakeholders along the health care continuum
· A data driven approach with practical considerations for clinicians and hospitals as the administration moves forward under the tight implementation timeline.